AI in Drug Discovery: Revolution or Hype? (heise.de)

• AI aims to cut drug development from an average of 10 years to just a few years.
• Several AI-discovered drug candidates are already in clinical trials.
• Critics warn of overblown expectations and lack of algorithm transparency.

"The pharmaceutical industry is increasingly using AI to accelerate drug discovery and reduce costs. AI tools analyze vast datasets to identify promising molecules. Experts see great potential but also challenges such as data quality and regulation. The article asks whether AI can truly be a magic bullet for drug development."